In this study, the methylation frequency of BCL2 was significantly higher in lung tissues of stage I NSCLC, than in non-cancerous lung diseases, and its methylation was positively associated with the expression of P53 in stage I NSCLC. The gene discussed is TP53; the disease is non-small cell lung carcinoma.